Literature DB >> 19070915

Iron in NASH, chronic liver diseases and HCC: how much iron is too much?

Antonello Pietrangelo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19070915     DOI: 10.1016/j.jhep.2008.11.011

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  20 in total

1.  Non-alcoholic fatty liver disease: is iron relevant?

Authors:  Julia O'Brien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2011-08-12       Impact factor: 6.047

2.  Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.

Authors:  Joanna Raszeja-Wyszomirska; Grzegorz Kurzawski; Malgorzata Lawniczak; Joanna Miezynska-Kurtycz; Jan Lubinski
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

3.  Gender-related variations in iron metabolism and liver diseases.

Authors:  Duygu D Harrison-Findik
Journal:  World J Hepatol       Date:  2010-08-27

Review 4.  Hepatic sexual dimorphism - implications for non-alcoholic fatty liver disease.

Authors:  Philippe Lefebvre; Bart Staels
Journal:  Nat Rev Endocrinol       Date:  2021-08-20       Impact factor: 43.330

Review 5.  Hepatic iron overload and hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

6.  Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome.

Authors:  Jordi Mayneris-Perxachs; Marina Cardellini; Lesley Hoyles; Jèssica Latorre; Francesca Davato; José Maria Moreno-Navarrete; María Arnoriaga-Rodríguez; Matteo Serino; James Abbott; Richard H Barton; Josep Puig; Xavier Fernández-Real; Wifredo Ricart; Christopher Tomlinson; Mark Woodbridge; Paolo Gentileschi; Sarah A Butcher; Elaine Holmes; Jeremy K Nicholson; Vicente Pérez-Brocal; Andrés Moya; Donald Mc Clain; Rémy Burcelin; Marc-Emmanuel Dumas; Massimo Federici; José-Manuel Fernández-Real
Journal:  Microbiome       Date:  2021-05-07       Impact factor: 14.650

Review 7.  Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy.

Authors:  Jianan Zhao; Yiyang Hu; Jinghua Peng
Journal:  Cell Mol Biol Lett       Date:  2021-05-07       Impact factor: 5.787

8.  High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats.

Authors:  Rosaria Meli; Giuseppina Mattace Raso; Carlo Irace; Raffaele Simeoli; Antonio Di Pascale; Orlando Paciello; Teresa Bruna Pagano; Antonio Calignano; Alfredo Colonna; Rita Santamaria
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

9.  Body iron, serum ferritin, and nonalcoholic fatty liver disease.

Authors:  Jae-Jun Shim
Journal:  Korean J Hepatol       Date:  2012-03-22

10.  The role of MR imaging in detection of hepatic iron overload in patients with cirrhosis of different origins.

Authors:  Edyta Szurowska; Katarzyna Sikorska; E Izycka-Swieszewska; Tomasz Nowicki; Tomasz Romanowski; Krzysztof P Bielawski; Michał Studniarek
Journal:  BMC Gastroenterol       Date:  2010-01-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.